Literature DB >> 17354020

QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism.

Susumu Matsuoka1, Yoshihiro Tominaga, Tetsuhiko Sato, Nobuaki Uno, Norihiko Goto, Akio Katayama, Kazuharu Uchida, Hiroshi Takami.   

Abstract

BACKGROUND: In uremic patients, metabolism of 1-84 parathyroid hormone (PTH) and fragments are delayed, and in these patients, the usefulness of intraoperative PTH assay may be problematic. We evaluated the usefulness of the QuiCk-IntraOperative Bio-Intact PTH (QPTH) assay for uremic patients with secondary hyperparathyroidism who required total parathyroidectomy (PTx) with forearm autograft. The purpose of our study was to recognize whether QPTH in uremic patients was useful to determine during operation whether complete PTx had been achieved.
METHODS: Forty-four patients who underwent initial PTx were enrolled in this study. Blood samples were drawn just after induction of general anesthesia (basal samples), immediately after removal of the last gland, and at 5, 10, 15, and 30 minutes, and at the first morning after PTx. The assay was performed immediately after sample collection. Reductions of PTH levels were evaluated and expressed in percentage of basal levels.
RESULTS: The mean PTH levels in 41 patients, excluding 3 in whom the PTH level did not drop significantly (>60 pg/ml), measured by QPTH at anesthesia, 0, 5, 10, 15, and 30 minutes were 734.3, 104.7, 58.8, 37.4, 27.0, 16.3 pg/ml, corresponding to 100%, 17.1%, 9.3%, 5.8%, 4.1%, 2.4% of the preexcision values, respectively. If the cutoff value was defined as 10.8% at 10 minutes, the sensitivity was 100% and specificity 90%. When the QPTH level dropped to under 10.8% at 10 minutes, we could consider that all glands were removed.
CONCLUSIONS: QPTH in uremic patients is very useful to determine whether complete PTx is achieved during operation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354020     DOI: 10.1007/s00268-006-0601-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

1.  Reoperation for renal hyperparathyroidism.

Authors:  Yatsuka Hibi; Yoshihiro Tominaga; Tetsuhiko Sato; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Toshihiro Ichimori; Masahiro Numano; Yuji Tanaka; Hiroshi Takagi; Tsuneo Imai; Hiroomi Funahashi; Akimasa Nakao
Journal:  World J Surg       Date:  2002-09-04       Impact factor: 3.352

2.  Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism.

Authors:  S K Libutti; H R Alexander; D L Bartlett; M L Sampson; M E Ruddel; M Skarulis; S J Marx; A M Spiegel; W Simmonds; A T Remaley
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

3.  The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.

Authors:  Silke V Haustein; Eberhard Mack; James R Starling; Herbert Chen
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

4.  Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay.

Authors:  S E Carty; J Worsey; M A Virji; M L Brown; C G Watson
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

5.  Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.

Authors:  J H Brossard; M Cloutier; L Roy; R Lepage; M Gascon-Barré; P D'Amour
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

6.  Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Tetsuhiko Sato
Journal:  Ther Apher Dial       Date:  2005-02       Impact factor: 1.762

7.  Surgical treatment of renal hyperparathyroidism.

Authors:  Y Tominaga; M Numano; Y Tanaka; K Uchida; H Takagi
Journal:  Semin Surg Oncol       Date:  1997 Mar-Apr

8.  Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy?

Authors:  Daishu Miura; Nobuyuki Wada; Cumhur Arici; Eugene Morita; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2002-04-30       Impact factor: 3.352

9.  Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients.

Authors:  Yoshihiro Tominaga; Akio Katayama; Tetsuhiko Sato; Susumu Matsuoka; Norihiko Goto; Toshihito Haba; Yatsuka Hibi; Masahiro Numano; Toshihiro Ichimori; Kazuharu Uchida
Journal:  Nephrol Dial Transplant       Date:  2003-06       Impact factor: 5.992

10.  Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.

Authors:  Klaus Kaczirek; Gerhard Prager; Philipp Riss; Gerald Wunderer; Reza Asari; Christian Scheuba; Christian Bieglmayer; Bruno Niederle
Journal:  Arch Surg       Date:  2006-02
View more
  10 in total

1.  Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis.

Authors:  Monica Jain; David L Krasne; Frederick R Singer; Armando E Giuliano
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

2.  Evaluation of the 'putative' role of intraoperative intact parathyroid hormone assay during parathyroidectomy for secondary hyperparathyroidism. A retrospective study on 35 consecutive patients: intraoperative iPTH assay during parathyroidectomy.

Authors:  G Conzo; A Perna; N Avenia; R M De Santo; C Della Pietra; A Palazzo; A A Sinisi; F Stanzione; L Santini
Journal:  Endocrine       Date:  2012-03-16       Impact factor: 3.633

3.  Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism.

Authors:  Elif Hindié; Paolo Zanotti-Fregonara; Pierre-Alexandre Just; Emile Sarfati; Didier Mellière; Marie-Elisabeth Toubert; Jean-Luc Moretti; Christian Jeanguillaume; Isabelle Keller; Pablo Ureña-Torres
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-28       Impact factor: 9.236

4.  Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism.

Authors:  Nobuaki Uno; Yoshihiro Tominaga; Susumu Matsuoka; Toyonori Tsuzuki; Shuichi Shimabukuro; Tetsuhiko Sato; Norihiko Goto; Takaharu Nagasaka; Akio Katayama; Kazuharu Uchida
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

5.  Location Frequency of Missed Parathyroid Glands After Parathyroidectomy in Patients with Persistent or Recurrent Secondary Hyperparathyroidism.

Authors:  Manabu Okada; Yoshihiro Tominaga; Takayuki Yamamoto; Takahisa Hiramitsu; Shunji Narumi; Yoshihiko Watarai
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

6.  Delayed sampling of intraoperative parathormone may be unnecessary during parathyroidectomy in kidney-transplanted and dialysis patients.

Authors:  Andre Albuquerque Silveira; Marilia D'Elboux Guimarães Brescia; Climério Pereira do Nascimento; Sergio Samir Arap; Fabio Luiz de Menezes Montenegro
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

7.  How radical is total parathyroidectomy in patients with renal hyperparathyroidism?

Authors:  Thomas Burgstaller; Andreas Selberherr; Lindsay Brammen; Christian Scheuba; Klaus Kaczirek; Philipp Riss
Journal:  Langenbecks Arch Surg       Date:  2018-12-05       Impact factor: 3.445

8.  Use of intraoperative parathyroid hormone measurements during parathyroidectomy to predict postoperative parathyroid hormone levels in patients with renal hyperparathyroidism: meta-analysis.

Authors:  Dirk-Jan van Beek; Stina Fredriksson; Stefanie Haegele; Marco Raffaelli; Philipp Riss; Martin Almquist
Journal:  BJS Open       Date:  2022-01-06

9.  The use of pre-operative imaging and intraoperative parathyroid hormone level to guide surgical management of tertiary hyperparathyroidism from X-linked hypophosphatemic rickets: a case report.

Authors:  Matthew D Neal; Berthony Deslouches; Jennifer Ogilvie
Journal:  Cases J       Date:  2009-09-10

10.  A Retrospective Study of the Impact of Intraoperative Intact Parathyroid Hormone Monitoring During Total Parathyroidectomy for Secondary Hyperparathyroidism: STARD Study.

Authors:  Takahisa Hiramitsu; Yoshihiro Tominaga; Manabu Okada; Takayuki Yamamoto; Takaaki Kobayashi
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.